Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses

por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado 2015

Quantum mechanics implementation in drug-design workflows: does it really help?

por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado 2017

An in-silico layer-by-layer adsorption study of the interaction between Rebaudioside A and the T1R2 human sweet taste receptor: modelling and biosensing perspectives

por Arodola, Olayide A., Kanchi, Suvardhan, Hloma, Phathisanani, Bisetty, Krishna, Asiri, Abdullah M., Inamuddin
Publicado 2020